To amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain shortage and urgent-use compounded medications, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Drug Shortage Compounding Patient Access Act of 2025. H.R. 5316. 119th
Cong., 1st
sess., Introduced in House September 11, 2025. https://www.govinfo.gov/app/details/BILLS-119hr5316ih.
APA
Congress, House of Representatives (2025, September 11). Drug Shortage Compounding Patient Access Act of 2025 (H.R. 5316 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr5316ih.
MLA
United States, Congress, House of Representatives. Drug Shortage Compounding Patient Access Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr5316ih. 119th Congress, H.R. 5316, Introduced in House 11 Sep. 2025.
Bluebook
H.R.5316 - 119th Congress (2025-2026): Drug Shortage Compounding Patient Access Act of 2025, H.R.5316, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr5316ih.
